Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease

NCT00053716 is registered in ClinicalTrials.gov with Endovasc as lead sponsor.

NCT NCT00053716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease
Lead sponsor
Endovasc
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2003
Completion date
August 31, 2003
Enrollment
12
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular disease